Top Markets
#1 Akedo Akedo +57.68%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +49.31%
#4 Cross Cross +43.97%
#5 OVERTAKE OVERTAKE +34.90%
#6 Black Phoenix Black Phoenix +34.01%
#7 Velvet Velvet +27.53%
#8 Cap Cap +15.60%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +15.31%
#10 Palladium Network Palladium Network +12.56%
Coin of the day
Akedo Akedo
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Classifica tra le azioni #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Prezzo delle azioni
$0.02243487
Ultima sincronizzazione: 2025-06-04
Capitalizzazione di mercato
$650.09K
Variazione (1 giorno)
0.39%
Variazione (1 anno)
0.00%
Paese
SE
Scambia Lipidor AB (publ) (LIPI)

Categoria

Healthcare
Utile per Lipidor AB (publ) (LIPI)
Utile nel Dec 2024 TTM: $-1.25M
Secondo gli ultimi rapporti finanziari di Lipidor AB (publ), gli utili attuali della società sono $-1.25M. Nel 2023, la società ha registrato un utile di $-1.14M, un aumento rispetto a agli utili del 2022, che erano di $-3.97M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Lipidor AB (publ) dal 2016 al 2026
Utile alla fine di ogni anno
Anno Utile Cambia
2026 (TTM) $-1.25M 0.00%
2024 $-1.25M 9.96%
2023 $-1.14M -71.31%
2022 $-3.97M 68.68%
2021 $-2.35M 19.98%
2020 $-1.96M 32.57%
2019 $-1.48M 73.02%
2018 $-854.84K 129.77%
2017 $-372.04K -30.69%
2016 $-536.78K 0.00%
Utile per aziende simili o concorrenti
Azienda Utile Differenza negli utili Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
$33.59B -2,683,842.70%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
$25.20B -2,012,923.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
$8.70B -695,033.61%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
$21.39B -1,708,738.18%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
$5.95B -475,265.55%
US